These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 15982734)

  • 1. Anti-angiogenesis effects of meisoindigo on chronic myelogenous leukemia in vitro.
    Xiao Z; Wang Y; Lu L; Li Z; Peng Z; Han Z; Hao Y
    Leuk Res; 2006 Jan; 30(1):54-9. PubMed ID: 15982734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Artesunate inhibits angiogenesis and downregulates vascular endothelial growth factor expression in chronic myeloid leukemia K562 cells.
    Zhou HJ; Wang WQ; Wu GD; Lee J; Li A
    Vascul Pharmacol; 2007; 47(2-3):131-8. PubMed ID: 17581794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Inducement effect of Meisoindigo on apoptosis of leukemia cell line HL-60 and its mechanism].
    Wang Y; Zhu XF; Xiao ZJ; Wang HH; Zhou JM; Mei YP; Deng R; Jiang WQ; Liu ZC
    Ai Zheng; 2005 Dec; 24(12):1464-8. PubMed ID: 16351793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of cloned tumstatin-related and angiogenesis-inhibitory peptides on proliferation and apoptosis of endothelial cells.
    Zhang GM; Zhang YM; Fu SB; Liu XH; Fu X; Yu Y; Zhang ZY
    Chin Med J (Engl); 2008 Nov; 121(22):2324-30. PubMed ID: 19080341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Study on the role of angiogenesis and related factors in leukemias].
    Zhang Y; Gu J; Wang M; Ma L; Wang XL; He B; Sun M
    Zhonghua Xue Ye Xue Za Zhi; 2005 Mar; 26(3):175-8. PubMed ID: 15946533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Angiogenesis in different clinical phases of chronic myeloid leukemia].
    Krasowska-Kwiecień A; Kijowski J; Łukasiewicz E; Sacha T; Foryciarz K; Majka M; Ratajczak MZ; Skotnicki AB
    Przegl Lek; 2009; 66(9):471-8. PubMed ID: 21033405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of antisense VEGF cDNA transfection on the growth of chronic myeloid leukemia K562 cells in vitro and in nude mice.
    Ruan GR; Liu YR; Chen SS; Fu JY; Chang Y; Qin YZ; Li JL; Yu H; Wang H
    Leuk Res; 2004 Jul; 28(7):763-9. PubMed ID: 15158098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. c-Jun blocks cell differentiation but not growth inhibition or apoptosis of chronic myelogenous leukemia cells induced by STI571 and by histone deacetylase inhibitors.
    Huang HM; Liu JC
    J Cell Physiol; 2009 Mar; 218(3):568-74. PubMed ID: 19006173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumor effects of celecoxib on K562 leukemia cells are mediated by cell-cycle arrest, caspase-3 activation, and downregulation of Cox-2 expression and are synergistic with hydroxyurea or imatinib.
    Zhang GS; Liu DS; Dai CW; Li RJ
    Am J Hematol; 2006 Apr; 81(4):242-55. PubMed ID: 16550520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of G-CSF on the proliferation and differentiation of bcr/abl(+)-CD34+ cells from CML patients].
    Li CY; Meng FY; Sun QX; Fu YB; Jiang QL; Yi ZS; Song LL
    Zhonghua Xue Ye Xue Za Zhi; 2007 Nov; 28(11):762-5. PubMed ID: 18457269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-leukemic activity of valproic acid and imatinib mesylate on human Ph+ ALL and CML cells in vitro.
    Kircher B; Schumacher P; Petzer A; Hoflehner E; Haun M; Wolf AM; Nachbaur D; Gastl G
    Eur J Haematol; 2009 Jul; 83(1):48-56. PubMed ID: 19226363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of ST1571 on the development of dendritic cells derived from bone marrow mononuclear cells in patients with chronic myeloid leukemia].
    Zheng SE; Jin J; Tong XM; Qian WB; Xue YQ
    Zhonghua Zhong Liu Za Zhi; 2006 Dec; 28(12):920-3. PubMed ID: 17533744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triptolide inhibits Bcr-Abl transcription and induces apoptosis in STI571-resistant chronic myelogenous leukemia cells harboring T315I mutation.
    Shi X; Jin Y; Cheng C; Zhang H; Zou W; Zheng Q; Lu Z; Chen Q; Lai Y; Pan J
    Clin Cancer Res; 2009 Mar; 15(5):1686-97. PubMed ID: 19240172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro effect of adenovirus-mediated human Gamma Interferon gene transfer into human mesenchymal stem cells for chronic myelogenous leukemia.
    Li X; Lu Y; Huang W; Xu H; Chen X; Geng Q; Fan H; Tan Y; Xue G; Jiang X
    Hematol Oncol; 2006 Sep; 24(3):151-8. PubMed ID: 16700092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The relationship between expression of the vascular endothelial growth factor and acute leukemia subtype].
    Ye XJ; Lin MF
    Zhonghua Xue Ye Xue Za Zhi; 2005 Jun; 26(6):363-6. PubMed ID: 16185486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of TNF-alpha and curcumin on the expression of VEGF in Raji and U937 cells and on angiogenesis in ECV304 cells.
    Chen WH; Chen Y; Cui GH
    Chin Med J (Engl); 2005 Dec; 118(24):2052-7. PubMed ID: 16438902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical detection of VEGF in the bone marrow of patients with chronic myeloid leukemia and correlation with the phase of disease.
    Krauth MT; Simonitsch I; Aichberger KJ; Mayerhofer M; Sperr WR; Sillaber C; Schneeweiss B; Mann G; Gadner H; Valent P
    Am J Clin Pathol; 2004 Apr; 121(4):473-81. PubMed ID: 15080298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bortezomib mediates antiangiogenesis in multiple myeloma via direct and indirect effects on endothelial cells.
    Roccaro AM; Hideshima T; Raje N; Kumar S; Ishitsuka K; Yasui H; Shiraishi N; Ribatti D; Nico B; Vacca A; Dammacco F; Richardson PG; Anderson KC
    Cancer Res; 2006 Jan; 66(1):184-91. PubMed ID: 16397231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AKT/NF-kappaB inhibitor xanthohumol targets cell growth and angiogenesis in hematologic malignancies.
    Dell'Eva R; Ambrosini C; Vannini N; Piaggio G; Albini A; Ferrari N
    Cancer; 2007 Nov; 110(9):2007-11. PubMed ID: 17823911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Berbamine: a novel inhibitor of bcr/abl fusion gene with potent anti-leukemia activity.
    Xu R; Dong Q; Yu Y; Zhao X; Gan X; Wu D; Lu Q; Xu X; Yu XF
    Leuk Res; 2006 Jan; 30(1):17-23. PubMed ID: 16023722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.